U.S. Health Care REITs Stock News

Why Entergy (ETR) is on investors’ radar today Entergy (ETR) is drawing fresh attention after recent trading left the stock with a last close of US$111.11, prompting investors to reassess the utility’s valuation, returns and core business profile. See our latest analysis for Entergy. Recent trading leaves Entergy’s 1 day share price return at 1.11% and year to date share price return at 18.38%. Its 1 year total shareholder return of 38.85% and 5 year total shareholder return of 156.74% point...

State Street (STT) is in focus after Principal Financial Group selected the company to provide custody, fund accounting and administration services for Principal Funds, putting its integrated investment servicing platform under a brighter spotlight for investors. See our latest analysis for State Street. For context, State Street’s recent client win comes as momentum in the stock has been building, with a 10.59% 1 month share price return and a 79.25% 1 year total shareholder return,...

Ulta Beauty (ULTA) just delivered a strong first quarter, with sales and earnings ahead of expectations and management lifting full year guidance. This gives investors fresh numbers to reassess the stock’s recent pullback. See our latest analysis for Ulta Beauty. The recent first quarter beat and raised guidance have not yet fully restored confidence, with the share price down about 25% year to date and around 13% over 90 days, even as the 5 year total shareholder return is about 43%...

The official opening of The Park Ward Village, with 97% of its 546 homes pre-sold and more than US$700 million in expected GAAP revenue recognition, puts Howard Hughes Holdings (HHH) back in focus for real estate investors. See our latest analysis for Howard Hughes Holdings. Recent trading reflects that tension between opportunity and risk, with a 30 day share price return of 4.13% and a year to date share price decline of 15.16%. Over 5 years, the total shareholder return is down 29.35%,...

In recent weeks Microsoft has faced a new securities class action alleging it misled investors about Copilot’s technical and adoption challenges, even as it redirected compute and billions of dollars of capital expenditure toward AI and disclosed capacity constraints in Azure. At the same time, Microsoft has continued to push deep AI deployments across sectors, from NHS England’s plan to roll out Microsoft 365 Copilot to more than 500,000 staff to a wave of new healthcare and enterprise AI...

Allegion recently expanded its electronic access control lineup at the Apartmentalize 2026 conference, unveiling interoperable Schlage XE360, Zentra and Gatewise integrations alongside a mobile-first Campus-to-Community platform for student housing. This push deeper into connected, software-enabled security ecosystems for multifamily and student housing highlights how Allegion is broadening beyond traditional mechanical lock hardware. We’ll now examine how Allegion’s new interoperable access...

Golar LNG (GLNG) is back in focus after recent commentary highlighted a squeeze between declining sales and a tightening cash runway. This has raised investor questions about the likelihood and implications of a potential capital raise. See our latest analysis for Golar LNG. The recent focus on Golar LNG’s cash runway comes after a mixed share price pattern, with the stock down about 10% over the past month but showing stronger momentum over the year, supported by a 35% year to date share...

Earlier this week, Viking Therapeutics appointed Hubert C. Chen, M.D., as chief medical officer, tasking him with leading clinical development, medical, and regulatory affairs as its metabolic and endocrine disorder programs advance. Dr. Chen’s track record in securing drug approvals and crafting regulatory strategies for complex therapies adds experienced oversight at a time when Viking’s obesity-focused pipeline is entering critical late-stage trials. We’ll now examine how Dr. Chen’s...

Select Water Solutions (WTTR) has been in focus after reporting earnings that exceeded analyst expectations on EPS and EBITDA, even as revenue was slightly lower year on year, drawing fresh attention to the stock’s recent move. See our latest analysis for Select Water Solutions. The stock has already reacted to the earnings beat with a 7.7% move higher, and at a latest share price of $18.91 that momentum is reflected in a 90 day share price return of 34.98% and a 1 year total shareholder...

In early June 2026, TGS, together with EPAM Systems and Amazon Web Services, reported the successful deployment of the TGS Imaging AnyWare seismic imaging platform on AWS, enabling faster, cloud-based, AI-enabled workflows for energy companies. This collaboration highlights EPAM’s role in building OSDU-compliant, cloud-native data and AI infrastructure for complex industrial workloads, potentially broadening its reach in the energy technology market. We’ll now examine how EPAM’s role in...

Block (XYZ) is back in focus after Q1 results topped guidance, management lifted its 2026 outlook, and the stock reacted to new financial products plus inclusion on Goldman Sachs’ US Conviction List. See our latest analysis for Block. At a share price of US$69.52, Block has seen a 2.01% 7 day share price return and a 16.27% 90 day share price return. The 1 year total shareholder return of 12.91% sits against headlines around Q1 earnings, new savings products, client case studies like Coffee...

Earlier this week, Merck reported that the FDA approved KEYTRUDA and KEYTRUDA QLEX, each in combination with WELIREG, as adjuvant therapy for adults with clear cell renal cell carcinoma at intermediate-high or high risk of recurrence following surgery, based on disease‑free survival gains in the Phase 3 LITESPARK‑022 trial. This decision introduces the first approved pairing of a PD-1 inhibitor with a HIF-2α inhibitor and extends WELIREG into earlier-stage kidney cancer, broadening Merck’s...

In recent days, Ryan Specialty Holdings reported weaker-than-expected fourth-quarter and full-year 2025 results, while also facing securities law investigations and hosting its investor presentation at the Morgan Stanley US Financials Conference 2026 in New York. At the same time, a mix of analyst downgrades, securities law scrutiny, and increased insider share purchases has put a spotlight on how confident management really is in the company’s long-term prospects. We’ll now examine how...

Needham’s new Buy rating on Hyliion Holdings (HYLN) has thrown a spotlight on the stock, with the firm highlighting the commercialization prospects for the KARNO power module and a debt-free balance sheet. See our latest analysis for Hyliion Holdings. Hyliion’s recent move follows a sharp re-rating, with the stock posting a 30 day share price return of 106.13% and a year to date share price return of 306.59%. The 1 year total shareholder return stands at 410.34%. If Hyliion’s surge has your...

Synchrony Financial (SYF) is back in focus after expanding its co brand partnership with Lowe’s and rolling out CareCredit across Pet Resort Hospitality Group locations, while recent monthly credit data points to steady portfolio performance. See our latest analysis for Synchrony Financial. The recent partnerships with Lowe’s and Pet Resort Hospitality Group, combined with steady credit metrics, come as the stock trades at US$73.36 after a 15.02% 90 day share price return, while the 3 year...

Virgin Galactic Holdings has recently redeemed about US$30.5 million of its 9.80% First Lien Notes by issuing roughly 6.73 million shares and filed a US$46.86 million shelf registration for nearly 9,950,000 common shares tied to an employee stock plan, reshaping its capital structure ahead of planned commercial spaceflights. These moves highlight the trade-off between near-term dilution and improved liquidity as Virgin Galactic works toward late-2026 commercial operations and seeks to...

In recent days, Nextpower has been swept up in sector-wide swings linked to shifting Iran-related geopolitical risks, which have affected solar and broader energy technology companies without any new company-specific announcements. At the same time, the company has remained a focus of investor attention with consistent earnings outperformance versus consensus, even as near-term earnings expectations and analyst sentiment have been mixed. We’ll now examine how this geopolitically driven...

SpaceX’s blockbuster IPO, with its 19% first day jump to $160 and an estimated $1.77t valuation, has pulled fresh attention toward recently listed stocks that traders see as potential momentum plays. When a headline listing captures the market’s imagination, it can spill over into other young IPOs that already show strong price moves and active trading. This article looks at 3 stocks from the IPO Momentum Stocks screener that appear closely tied to this surge in enthusiasm around newly public...

Earlier this month, Digital Turbine launched Launchpad, a unified app distribution platform that ties together carrier and OEM integrations, SingleTap installs, direct app relationships, and a footprint of more than 82,000 apps across over 1.00 billion devices to power modern app discovery and installs. The platform is already being used by game developers such as Zynga, Playtika, King and mobile partners including Orange, Motorola, and Telefónica, highlighting how on-device distribution and...

With inflation running at 4.2% on CPI, 6.5% on PPI and rate markets now pricing in a possible hike rather than cuts, income investors are suddenly playing a different game. Higher yields and a firm labor market can reward companies that already generate solid cash flow, carry manageable debt and keep dividends on a realistic footing. This article focuses on three stocks from a High Quality Dividend Stocks screener that fit that description and are directly exposed to the current interest rate...

Why W. R. Berkley (WRB) is Drawing Fresh Investor Attention W. R. Berkley (WRB) has been back on investors’ radar after recent trading left the stock with a mixed return profile, including a decline over the past year alongside solid multi year total returns. See our latest analysis for W. R. Berkley. Recent trading has been choppy, with a 1 day share price return of 1.08% and a 1 month share price return of 4.34%. The 1 year total shareholder return is down 4.36%, compared with much stronger...

Organon (OGN) is back in focus after the US Food and Drug Administration approved an expanded label for its tocilizumab biosimilar, TOFIDENCE, adding indications for severe cytokine release syndrome and certain hospitalized COVID-19 patients. See our latest analysis for Organon. At a latest share price of US$13.44, Organon’s 90 day share price return of 111.65% and year to date share price return of 85.64% contrast with a 3 year total shareholder return that declined 27.03%. This suggests...

Apple (AAPL) is back in focus after its Worldwide Developers Conference, where the company revealed a revamped Siri AI and broader Apple Intelligence rollout, only to see the stock sell off on investor disappointment. See our latest analysis for Apple. The stock reaction around WWDC has been choppy, with a 1-day share price return of down 1.52% and a 7-day share price return of down 5.27% as investors reassessed the impact of Siri AI and Apple Intelligence. This is occurring even though the...

Macy’s, Inc. recently reported first-quarter 2026 results, with revenue of US$4,892 million and net income of US$63 million, and modestly raised its full-year net sales guidance to US$21.5 billion–US$21.75 billion, while also updating its ongoing share repurchase activity. Following these updates, several Wall Street firms upgraded their outlook on Macy’s turnaround efforts, highlighting improving operations even as some insiders sold shares and the company continues to face store closures...